SRI Can Help Improve Your NIH Grant Application Success Rate

Our Experience on Your Side
SRI's tremendous experience and proven track record with NIH (National Institutes of Health) can help you win your next grant application. Working with NIH since 1956, SRI is a major contractor and grantee for nonclinical research and development for numerous NIH Institutes, including the National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, National Institute on Drug Abuse, and others. SRI has a wealth of insight into how these programs select and develop new drugs and vaccines. SRI operates a large Washington, DC, office whose primary responsibility is to identify and facilitate new government relationships with NIH and maximize exposure of our business partners. SRI's own success rate at NIH has been extraordinary.

Putting This Experience To Work To Help You Succeed
SRI can assist large and small companies in winning government grants, including awards from NIH's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs.

We can provide:

• Consulting on overall government support strategies
• Identification of potential funding opportunities
• Marketing of new programs to NIH decision makers
• Interaction with program heads to determine suitability and interest of specific proposals
• Assistance in all aspects of grant application and contract proposal preparation and submission
• Assistance in navigating the web of government procurement regulations and contracting procedures
• A sustainable environment and team for carrying out parts of the research - as a subcontractor - when appropriate

SRI as Your Partner and Collaborator
Teaming with SRI provides a wealth of benefits. We not only provide tremendous insight but can also execute all the nonclinical development tasks needed to get a new drug or biological from the lab into the clinic. We offer facilities compliant with the FDA's GLP (Good Laboratory Practice) and cGMP (current Good Manufacturing Practice) regulations and an expert staff to carry out the tasks required by regulatory agencies that most universities and small businesses are not capable of doing. Having SRI on your team assures NIH that your work will be:

• Carried out in accredited and NIH-compliant animal facilities
• FDA acceptable (no SRI GLP study submitted to the FDA has been rejected)
• Performed according to NIH's own study design requirements (many of which were developed at SRI)
• Accomplished by a stable institution with over 55 years of documented performance

Complete Drug Development Service
SRI offers comprehensive drug development services, including:

• Drug development planning
• Custom synthesis, including radiosynthesis
• Drug substance preparation
• Formulation studies
• Safety studies
• Pharmacokinetics and biodistribution (PK/ADME) studies
• Analytical services
• Investigational New Drug (IND) application assembly and filing
• Clinical Trials Material manufacturing

We Focus on What You Need
SRI's long-standing reputation and vast knowledge of NIH can provide you with the support and services you need to make your NIH grant successful. Whether you need consulting, assistance in understanding the NIH market, or teaming for preclinical development services, SRI can deliver.

Contact Us

       Last Updated Jul 7, 2006